Hot-melt extrusion in the pharmaceutical industry: toward filing a new drug application

The pharmaceutical development of amorphous solid dispersions (ASDs) by hot-melt extrusion (HME) is briefly reviewed. A systematic step-by-step approach is presented, where thermodynamics, polymer screening, multivariate statistics and process optimization are combined, to increase the success of HME-based drug product development.

Handbook of Nutraceuticals

Soluplus® as Promising Polymer for Topical Film Forming Solid Solutions of Betamethasone Dipropionate (BDP)

Novel fast dissolving freeze dried sublingual baicalin tablets for enhanced hepatoprotective effect: in-vitro characterization, cell viability, and in-vivo evaluation

The quality by design (QbD) concept is introduced and applied to HME. Steps and tools for its effective implementation are provided, including risk assessment highlighting crucial points. The technical and scientific specificities of HME-based ASDs are discussed in light of the current paradigm of drug development and in-line with regulatory guidelines from the ICH regions. Case studies of recently approved HME products are presented.

Download the full article here: hot-melt-extrusion-in-the-pharmaceutical-industry-toward-filing-a-new-drug-application.pdf

excipients